With this model, the same lab recently utilized NMR-based metabolomic analysis to profile changes in a number of metabolic pathways in non-tumor lymphocytes, pre-tumor MYC-driven lymphocytes, lymphocytes with reduced translation, MYC-driven lymphocytes with normalized translation, and tumorigenic MYC-driven lymphocytes. The gene discussed is MYC; the disease is neoplasm.